Goldman Sachs Initiates Buy On Syngene, Neuland Labs & A Sell Rating On Laurus Labs | CNBC TV18
1 week ago•CNBC-TV18
Syngene To Neuland And Laurus: Goldman Sachs Initiates Coverage As India Expands Global Pharma Supply
1 week ago•Bloomberg Quint
Syngene Under Pressure As Mgmt Cuts FY24 Revenue Growth Guidance After Reporting Weak Q3 | CNBC TV18
2 months ago•CNBC-TV18
Syngene International Downgraded To ‘Sell’ By UBS On Revenue Growth Headwinds
3 months ago•Bloomberg Quint
Top Stock Picks By Gaurav Bissa Of Incred Equities; Syngene, HDFC Life | Stocks To Buy Today
4 months ago•ET NOW
Q2 Review: Strong Q2 For Syngene International
6 months ago•Bloomberg Quint
Syngene International Q2 net profit rises 14.22% to Rs 116.5 crore
6 months ago•Moneycontrol